Rxsight Inc Share Price Today: Live Updates & Key Insights

Rxsight Inc share price today is $6.44, up -4.45%. The stock opened at $6.63 against the previous close of $6.74, with an intraday high of $6.82 and low of $6.355.

Rxsight Inc Share Price Chart

Rxsight Inc

us-stock
To Invest in {{usstockname}}
us-stock

Rxsight Inc Share Price Performance

$6.44 -0.0445(-4.45%) RXST at 23 Mar 2026 03:06 PM Medical Devices
Lowest Today 6.355
Highest Today 6.82
Today’s Open 6.63
Prev. Close 6.74
52 Week High 27.13
52 Week Low 6.32
Day’s Range: Low 6.355 High 6.82
52-Week Range: Low 6.32 High 27.13
1 day return -
1 Week return -13.78
1 month return -27.19
3 month return -47.36
6 month return -32.28
1 year return -74.2
3 year return -59.36
5 year return -60.96
10 year return -

Rxsight Inc Institutional Holdings

BlackRock Inc 6.55

Vanguard Group Inc 5.40

Artisan Partners Limited Partnership 5.23

Millennium Management LLC 5.16

No Street GP LP 4.79

D. E. Shaw & Co LP 4.57

Artisan International Small-Mid Investor 3.22

Artisan Non-U.S. Small-Mid Growth Comp 3.22

Vanguard Total Stock Mkt Idx Inv 2.97

Citadel Advisors Llc 2.53

BNP Paribas Arbitrage, SA 2.36

Deutsche Bank AG 2.34

Defilade Capital Management, L.P. 2.21

iShares Russell 2000 ETF 2.06

Morgan Stanley - Brokerage Accounts 2.05

Geode Capital Management, LLC 2.03

State Street Corp 2.00

Two Sigma Investments LLC 1.93

UBS Group AG 1.78

Two Sigma Advisers, LLC 1.77

Xtrackers MSCI World Swap ETF 1C 1.77

Bank of America Corp 1.75

Baillie Gifford & Co Limited. 1.68

Nuveen, LLC 1.29

Royal Bank of Canada 1.20

Vanguard Institutional Extnd Mkt Idx Tr 0.94

Fidelity Small Cap Index 0.83

Brown Capital Mgmt Small Co Inv 0.76

iShares Russell 2000 Growth ETF 0.72

Bridge Builder Small/Mid Cap Growth 0.70

State St Russell Sm/Mid Cp® Indx SL Cl I 0.50

Fidelity Extended Market Index 0.45

Schwab US Small-Cap ETF™ 0.43

Federated Hermes MDT SCC Institutional 0.41

Federated Hermes MDT Small Cap Core IS 0.41

Vanguard Russell 2000 ETF 0.40

Baillie Gifford Global Discovery A Acc 0.38

Grandeur Peak Global Contrarian Instl 0.34

Grandeur Peak Global Opportunities Instl 0.33

State St Russell Sm Cap® Indx SL Cl I 0.30

Rxsight Inc Market Status

Strong Buy: 4

Buy: 2

Hold: 3

Sell: 2

Strong Sell: 0

Rxsight Inc Fundamentals

Market Cap 265.76 M

PB Ratio 0.9625

PE Ratio 0.0

Enterprise Value 48.25 M

Total Assets 311.81 M

Volume 1083648

Rxsight Inc Company Financials

Annual Revenue FY25:134477000 134.5M, FY24:139927000 139.9M, FY23:76585000 76.6M, FY22:49005000 49.0M, FY21:22593000 22.6M

Annual Profit FY25:103008000 103.0M, FY24:98943000 98.9M, FY23:43533000 43.5M, FY22:21328000 21.3M, FY21:4517000 4.5M

Annual Net worth FY25:-38943000 -38.9M, FY24:-27455000 -27.5M, FY23:-55041000 -55.0M, FY22:-66756000 -66.8M, FY21:-48688000 -48.7M

Quarterly Revenue Q4/2025:32607000 32.6M, Q3/2025:30340000 30.3M, Q2/2025:33637000 33.6M, Q1/2025:37895000 37.9M, Q3/2024:45408000 45.4M

Quarterly Profit Q4/2025:25263000 25.3M, Q3/2025:24227000 24.2M, Q2/2025:25190000 25.2M, Q1/2025:28329000 28.3M, Q3/2024:25220000 25.2M

Quarterly Net worth Q4/2025:-9151000 -9.2M, Q3/2025:-9816000 -9.8M, Q2/2025:-11786000 -11.8M, Q1/2025:-8190000 -8.2M, Q3/2024:-6338000 -6.3M

About Rxsight Inc & investment objective

Company Information RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Organisation Medical Devices

Employees 461

Industry Medical Devices

CEO Dr. Ronald M. Kurtz M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Rxsight Inc FAQs

What is the share price of Rxsight Inc today?

The current share price of Rxsight Inc is $6.44.

Can I buy Rxsight Inc shares in India?

Yes, Indian investors can buy Rxsight Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Rxsight Inc shares in India?

You can easily invest in Rxsight Inc shares from India by:

Can I buy fractional shares of Rxsight Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Rxsight Inc?

Rxsight Inc has a market cap of $265.76 M.

In which sector does Rxsight Inc belong?

Rxsight Inc operates in the Medical Devices sector.

What documents are required to invest in Rxsight Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Rxsight Inc?

The PE ratio of Rxsight Inc is N/A and the PB ratio is 0.96.